We are live on
!
Find out more
CRWM
Castle Rock Wealth Management Portfolio holdings
AUM
$531M
Turnover
12.89%
1-Year Est. Return
31.77%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+31.77%
3 Year Est. Return
+115.4%
5 Year Est. Return
+134.11%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$14.7M
(+15%)
Cap. Flow
+$6.93M
Cap. Flow
% of AUM
6.25%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
176
New
18
Increased
90
Reduced
37
Closed
9
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.25M |
| 2 |
Innovator US Equity Ultra Buffer ETF December
UDEC
|
+$890K |
| 3 |
Global X SuperDividend REIT ETF
SRET
|
+$711K |
| 4 |
Global X NASDAQ-100 Covered Call ETF
QYLD
|
+$705K |
| 5 |
Procter & Gamble
PG
|
+$703K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GLOP
GASLOG PARTNERS LP
GLOP
|
+$1.71M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$751K |
| 3 |
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
|
+$722K |
| 4 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$692K |
| 5 |
CVS Health
CVS
|
+$624K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.74% |
| 2 | Technology | 11.49% |
| 3 | Healthcare | 8.76% |
| 4 | Financials | 6.78% |
| 5 | Consumer Discretionary | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.75T
| $3.97M | 3.57% |
36,880
+20
| +0.1% | +$1.77K |
2019 Q2
2 quarters
|
|
2
Apple
AAPL
$4.99T
| $3.86M | 3.47% |
48,240
+668
| +1% | +$43K |
2019 Q1
3 quarters
|
|
3
Microsoft
MSFT
$4.01T
| $2.63M | 2.37% |
14,267
+1,070
| +8% | +$157K |
2019 Q1
3 quarters
|
|
4
Chevron
CVX
$430B
| $2.61M | 2.35% |
23,445
+19
| +0.1% | +$2.24K |
2019 Q1
3 quarters
|
|
5
Visa
V
$750B
| $2.53M | 2.28% |
12,397
-188
| -1% | -$33.9K |
2019 Q2
2 quarters
|
|
|
6
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.9B
| $1.67M | 1.51% |
16,667
-6,895
| -29% | -$692K |
2019 Q2
2 quarters
|
|
7
Berkshire Hathaway Class B
BRK.B
$1.13T
| $1.59M | 1.43% |
7,005
-994
| -12% | -$216K |
2019 Q2
2 quarters
|
|
8
UnitedHealth
UNH
$365B
| $1.57M | 1.42% |
5,414
+1,047
| +24% | +$274K |
2019 Q2
2 quarters
|
|
9
Walt Disney
DIS
$191B
| $1.55M | 1.39% |
10,972
+244
| +2% | +$34.1K |
2019 Q2
2 quarters
|
|
|
10
iShares 7-10 Year Treasury Bond ETF
IEF
$41.7B
| $1.53M | 1.38% |
13,559
-6,738
| -33% | -$751K |
2019 Q3
1 quarter
|
|
11
Saba Opportunistically Hedged Closed-End Funds ETF
CEFS
$427M
| $1.52M | 1.37% |
72,417
+5,810
| +9% | +$117K |
2019 Q3
1 quarter
|
|
12
Abbott
ABT
$181B
| $1.44M | 1.3% |
16,192
+748
| +5% | +$62.6K |
2019 Q1
3 quarters
|
|
|
13
Thermo Fisher Scientific
TMO
$258B
| $1.4M | 1.26% |
+4,130
| New | +$1.25M |
2019 Q4
0 quarters
|
|
14
Home Depot
HD
$308B
| $1.39M | 1.25% |
5,764
+290
| +5% | +$65.7K |
2017 Q4
8 quarters
|
|
15
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$972M
| $1.38M | 1.24% |
25,672
+1,004
| +4% | +$52.6K |
2019 Q1
3 quarters
|
|
16
Janus Henderson Short Duration Income ETF
VNLA
$3.56B
| $1.22M | 1.1% |
24,451
-2,378
| -9% | -$118K |
2019 Q1
3 quarters
|
|
|
17
Procter & Gamble
PG
$365B
| $1.21M | 1.09% |
9,734
+5,745
| +144% | +$703K |
2019 Q3
1 quarter
|
|
18
AT&T
T
$161B
| $1.16M | 1.04% |
40,096
+2,378
| +6% | +$68.7K |
2019 Q1
3 quarters
|
|
19
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.2B
| $1.16M | 1.04% |
3,942
+523
| +15% | +$144K |
2019 Q2
2 quarters
|
|
20
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.3B
| $1.13M | 1.02% |
19,151
+593
| +3% | +$31.9K |
2019 Q1
3 quarters
|
|
21
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
| $1.13M | 1.01% |
9,543
+4
| +0% | +$444 |
2019 Q3
1 quarter
|
|
22
Nuveen California Quality Municipal Income Fund
NAC
$1.58B
| $1.07M | 0.96% |
68,760
-1,114
| -2% | -$16.6K |
2017 Q4
8 quarters
|
|
23
NVIDIA
NVDA
$5.25T
| $1.05M | 0.95% |
157,480
+83,240
| +112% | +$433K |
2019 Q2
2 quarters
|
|
24
Invesco Preferred ETF
PGX
$3.64B
| $1.05M | 0.95% |
69,063
+18,239
| +36% | +$272K |
2017 Q4
8 quarters
|
|
25
Alphabet (Google) Class C
GOOG
$4.22T
| $1.04M | 0.94% |
13,840
+2,080
| +18% | +$134K |
2019 Q2
2 quarters
|
|
Similar funds
KM
NAMP
IA
ICP
FIG
OSNBOA
TCMP
AWAU
Castle Rock Wealth Management's Q4 2019 Portfolio in Review
As of Q4 2019, Castle Rock Wealth Management held 176 positions worth $111M, up 15% from $96.3M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Castle Rock Wealth Management deployed $6.93M of net new capital in Q4 2019, opening 18 new positions and adding to 90 existing holdings. Its largest new stake was Thermo Fisher Scientific: 4,130 shares worth $1.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 44% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares 7-10 Year Treasury Bond ETF, an estimated $751K trimmed.
- Castle Rock Wealth Management's largest Q4 2019 buy was Thermo Fisher Scientific: 4,130 shares worth $1.4M.
- Castle Rock Wealth Management added most to Procter & Gamble in Q4 2019, an estimated $703K increase.
- Castle Rock Wealth Management's biggest Q4 2019 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $751K.
- Castle Rock Wealth Management fully exited GASLOG PARTNERS LP in Q4 2019, selling an estimated $1.71M.
- Castle Rock Wealth Management's ten largest holdings make up 21% of its $111M portfolio in Q4 2019.
- Castle Rock Wealth Management opened 18 new positions and closed 9 in Q4 2019.
- Castle Rock Wealth Management's portfolio value rose 15% quarter-over-quarter to $111M.
Based on Castle Rock Wealth Management's 13F filing for Q4 2019, filed 13 Feb 2020.